Clinical Trials on Alzheimer’s Disease Conference 2025
Clinical Trials on Alzheimer’s Disease Conference
1 t/m 4 december 2025 | San Diego, VS | For English, see below
De jaarlijkse Clinical Trials on Alzheimer’s Disease-conferentie (CTAD) is volledig gericht op klinische studies naar de ziekte van Alzheimer.
Gerenommeerde onderzoekers uit de industrie en de academische wereld ontmoeten elkaar tijdens de 18e editie (CTAD25) voor kennisuitwisseling en samenwerking, om de ontwikkeling van effectieve behandelingen tegen de ziekte van Alzheimer te versnellen.
- De eeste call for Abstracts is gesloten
- Een late call for abstracts opent op 1 augustus; de deadline voor indiening is 30 september 2025.
Speed the development of effective treatments
The annual Clinical Trials on Alzheimer’s Disease conference is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials. Key leaders in Alzheimer Disease research from Industry and Academia will get together during the 18th edition in San Diego, US (CTAD25) and form partnerships with the objective of speeding the development of effective treatments to fight the disease.
- The call for Abstracts is closed
- A late call for abstracts will open on August 1st with a submission deadline on September 30th 2025.
For more information and registration, please follow the link below.